Opus Genetics (IRD) Return on Equity (2021 - 2024)
Opus Genetics (IRD) has disclosed Return on Equity for 6 consecutive years, with 3.05% as the latest value for Q3 2022.
- On a quarterly basis, Return on Equity fell 296.0% to 3.05% in Q3 2022 year-over-year; TTM through Sep 2022 was 3.05%, a 296.0% decrease, with the full-year FY2022 number at 0.52%, changed N/A from a year prior.
- Return on Equity was 3.05% for Q3 2022 at Opus Genetics, down from 2.53% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.09% in Q3 2021 to a low of 3.05% in Q3 2022.